396 research outputs found

    Insights into the formation mechanism of two-dimensional lead halide nanostructures

    Get PDF
    We present a colloidal synthesis strategy for lead halide nanosheets with a thickness of far below 100 nm. Due to the layered structure and the synthesis parameters the crystals of PbI2 are initially composed of many polytypes. We propose a mechanism which gives insight into the chemical process of the PbI2 formation. Further, we found that the crystal structure changes with increasing reaction temperature or by performing the synthesis for longer time periods changing for the final 2H structure. In addition, we demonstrate a route to prepare nanosheets of lead bromide as well as lead chloride in a similar way. Lead halides can be used as a detector material for high-energy photons including gamma and X-rays

    Multiplicity Distributions and Charged-neutral Fluctuations

    Get PDF
    Results from the multiplicity distributions of inclusive photons and charged particles, scaling of particle multiplicities, event-by-event multiplicity fluctuations, and charged-neutral fluctuations in 158โ‹…A\cdot A GeV Pb+Pb collisions are presented and discussed. A scaling of charged particle multiplicity as Npart1.07ยฑ0.05N_{part}^{1.07\pm 0.05} and photons as Npart1.12ยฑ0.03N_{part}^{1.12\pm 0.03} have been observed, indicating violation of naive wounded nucleon model. The analysis of localized charged-neutral fluctuation indicates a model-independent demonstration of non-statistical fluctuations in both charged particles and photons in limited azimuthal regions. However, no correlated charged-neutral fluctuations are observed.Comment: Talk given at the International Symposium on Nuclear Physics (ISNP-2000), Mumbai, India, 18-22 Dec 2000, Proceedings to be published in Pramana, Journal of Physic

    Spin dynamics in semiconductors

    Full text link
    This article reviews the current status of spin dynamics in semiconductors which has achieved a lot of progress in the past years due to the fast growing field of semiconductor spintronics. The primary focus is the theoretical and experimental developments of spin relaxation and dephasing in both spin precession in time domain and spin diffusion and transport in spacial domain. A fully microscopic many-body investigation on spin dynamics based on the kinetic spin Bloch equation approach is reviewed comprehensively.Comment: a review article with 193 pages and 1103 references. To be published in Physics Reports

    Biocompatibility and Biodegradation Studies of Subconjunctival Implants in Rabbit Eyes

    Get PDF
    Sustained ocular drug delivery is difficult to achieve. Most drugs have poor penetration due to the multiple physiological barriers of the eye and are rapidly cleared if applied topically. Biodegradable subconjunctival implants with controlled drug release may circumvent these two problems. In our study, two microfilms (poly [d,l-lactide-co-glycolide] PLGA and poly[d,l-lactide-co-caprolactone] PLC were developed and evaluated for their degradation behavior in vitro and in vivo. We also evaluated the biocompatibility of both microfilms. Eighteen eyes (9 rabbits) were surgically implanted with one type of microfilm in each eye. Serial anterior-segment optical coherence tomography (AS-OCT) scans together with serial slit-lamp microscopy allowed us to measure thickness and cross-sectional area of the microfilms. In vitro studies revealed bulk degradation kinetics for both microfilms, while in vivo studies demonstrated surface erosion kinetics. Serial slit-lamp microscopy revealed no significant inflammation or vascularization in both types of implants (mean increase in vascularity grade PLGA50/50 12ยฑ0.5% vs. PLC70/30 15ยฑ0.6%; Pโ€Š=โ€Š0.91) over a period of 6 months. Histology, immunohistochemistry and immuno-fluorescence also revealed no significant inflammatory reaction from either of the microfilms, which confirmed that both microfilms are biocompatible. The duration of the drug delivery can be tailored by selecting the materials, which have different degradation kinetics, to suit the desired clinical therapeutic application

    Nanoparticles for hyperthermia applications

    Get PDF
    Cancer is one of the leading causes of death worldwide, and unfortunately many cancer treatments have severe side effects. In order to avoid these, recent investigations into new oncological treatments have been carried out. In this context, composite biomaterials have been developed mainly from biopolymers or magnetic hydroxyapatite nanoparticles with the aim of directing and releasing drugs by means of an external magnetic field (hyperthermia). This chapter reviews recent advances in nanoparticle (NP) systems for hyperthermia applications with particular emphasis on the heating mechanisms of iron NPs (INPs) and their applications as composite biomaterials.Fil: Gutiรฉrrez Carmona, Tomy Josรฉ. Consejo Nacional de Investigaciones Cientรญficas y Tรฉcnicas. Centro Cientรญfico Tecnolรณgico Conicet - Mar del Plata. Instituto de Investigaciones en Ciencia y Tecnologรญa de Materiales. Universidad Nacional de Mar del Plata. Facultad de Ingenierรญa. Instituto de Investigaciones en Ciencia y Tecnologรญa de Materiales; ArgentinaFil: Alvarez, Vera Alejandra. Consejo Nacional de Investigaciones Cientรญficas y Tรฉcnicas. Centro Cientรญfico Tecnolรณgico Conicet - Mar del Plata. Instituto de Investigaciones en Ciencia y Tecnologรญa de Materiales. Universidad Nacional de Mar del Plata. Facultad de Ingenierรญa. Instituto de Investigaciones en Ciencia y Tecnologรญa de Materiales; Argentin

    Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells

    Get PDF
    Canonical Wnt/ฮฒ-catenin signaling has been suggested to promote self-renewal of pluripotent mouse and human embryonic stem cells. Here, we show that SB-216763, a glycogen synthase kinase-3 (GSK3) inhibitor, can maintain mouse embryonic stem cells (mESCs) in a pluripotent state in the absence of exogenous leukemia inhibitory factor (LIF) when cultured on mouse embryonic fibroblasts (MEFs). MESCs maintained with SB-216763 for one month were morphologically indistinguishable from LIF-treated mESCs and expressed pluripotent-specific genes Oct4, Sox2, and Nanog. Furthermore, Nanog immunostaining was more homogenous in SB-216763-treated colonies compared to LIF. Embryoid bodies (EBs) prepared from these mESCs expressed early-stage markers for all three germ layers, and could efficiently differentiate into cardiac-like cells and MAP2-immunoreactive neurons. To our knowledge, SB-216763 is the first GSK3 inhibitor that can promote self-renewal of mESC co-cultured with MEFs for more than two months

    Aag DNA Glycosylase Promotes Alkylation-Induced Tissue Damage Mediated by Parp1

    Get PDF
    Alkylating agents comprise a major class of front-line cancer chemotherapeutic compounds, and while these agents effectively kill tumor cells, they also damage healthy tissues. Although base excision repair (BER) is essential in repairing DNA alkylation damage, under certain conditions, initiation of BER can be detrimental. Here we illustrate that the alkyladenine DNA glycosylase (AAG) mediates alkylation-induced tissue damage and whole-animal lethality following exposure to alkylating agents. Aag-dependent tissue damage, as observed in cerebellar granule cells, splenocytes, thymocytes, bone marrow cells, pancreatic ฮฒ-cells, and retinal photoreceptor cells, was detected in wild-type mice, exacerbated in Aag transgenic mice, and completely suppressed in Aagโˆ’/โˆ’ mice. Additional genetic experiments dissected the effects of modulating both BER and Parp1 on alkylation sensitivity in mice and determined that Aag acts upstream of Parp1 in alkylation-induced tissue damage; in fact, cytotoxicity in WT and Aag transgenic mice was abrogated in the absence of Parp1. These results provide in vivo evidence that Aag-initiated BER may play a critical role in determining the side-effects of alkylating agent chemotherapies and that Parp1 plays a crucial role in Aag-mediated tissue damage.National Institutes of Health (U.S.) (NIH grant R01-CA075576)National Institutes of Health (U.S.) (NIH grant R01-CA055042)National Institutes of Health (U.S.) (NIH grant R01-CA149261)National Institutes of Health (U.S.) (NIH grant P30-ES00002)National Institutes of Health (U.S.) (NIH grant P30-ES02109)National Center for Research Resources (U.S.) (grant number M01RR-01066)National Center for Research Resources (U.S.) (grant number UL1 RR025758, Harvard Clinical and Translational Science Center

    Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects

    Get PDF
    Controlled release delivery is available for many routes of administration and offers many advantages (as microparticles and nanoparticles) over immediate release delivery. These advantages include reduced dosing frequency, better therapeutic control, fewer side effects, and, consequently, these dosage forms are well accepted by patients. Advances in polymer material science, particle engineering design, manufacture, and nanotechnology have led the way to the introduction of several marketed controlled release products and several more are in pre-clinical and clinical development
    • โ€ฆ
    corecore